Detalles de la búsqueda
1.
Emergence of cefiderocol resistance during ceftazidime/avibactam treatment caused by a large genomic deletion, including ampD and piuCD genes, in Pseudomonas aeruginosa.
Antimicrob Agents Chemother
; 68(1): e0119223, 2024 Jan 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-38063398
2.
Transferable AmpCs in Klebsiella pneumoniae: interplay with peptidoglycan recycling, mechanisms of hyperproduction, and virulence implications.
Antimicrob Agents Chemother
; 68(5): e0131523, 2024 May 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38517189
3.
In vitro activity of cefiderocol in Pseudomonas aeruginosa isolates from people with cystic fibrosis recovered during three multicentre studies in Spain.
J Antimicrob Chemother
; 79(6): 1432-1440, 2024 Jun 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38708553
4.
Deciphering mechanisms affecting cefepime-taniborbactam in vitro activity in carbapenemase-producing Enterobacterales and carbapenem-resistant Pseudomonas spp. isolates recovered during a surveillance study in Spain.
Eur J Clin Microbiol Infect Dis
; 43(2): 279-296, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38041722
5.
Biochemical Insights into Imipenem Collateral Susceptibility Driven by ampC Mutations Conferring Ceftolozane/Tazobactam Resistance in Pseudomonas aeruginosa.
Antimicrob Agents Chemother
; 67(2): e0140922, 2023 02 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-36715512
6.
Penicillin-Binding Protein 5/6 Acting as a Decoy Target in Pseudomonas aeruginosa Identified by Whole-Cell Receptor Binding and Quantitative Systems Pharmacology.
Antimicrob Agents Chemother
; 67(6): e0160322, 2023 06 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37199612
7.
Ceftolozane-Tazobactam against Pseudomonas aeruginosa Cystic Fibrosis Clinical Isolates in the Hollow-Fiber Infection Model: Challenges Imposed by Hypermutability and Heteroresistance.
Antimicrob Agents Chemother
; 67(8): e0041423, 2023 08 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-37428034
8.
In vitro dynamics and mechanisms of cefiderocol resistance development in wild-type, mutator and XDR Pseudomonas aeruginosa.
J Antimicrob Chemother
; 78(7): 1785-1794, 2023 07 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37253034
9.
Simultaneous and divergent evolution of resistance to cephalosporin/ß-lactamase inhibitor combinations and imipenem/relebactam following ceftazidime/avibactam treatment of MDR Pseudomonas aeruginosa infections.
J Antimicrob Chemother
; 78(5): 1195-1200, 2023 05 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36918743
10.
Significant increase of CTX-M-15-ST131 and emergence of CTX-M-27-ST131 Escherichia coli high-risk clones causing healthcare-associated bacteraemia of urinary origin in Spain (ITUBRAS-2 project).
J Antimicrob Chemother
; 78(9): 2291-2296, 2023 09 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37533351
11.
Elevated complement C3 and increased CD8 and type 1 helper lymphocyte T populations in patients with post-COVID-19 condition.
Cytokine
; 169: 156295, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37453328
12.
Outcomes of octogenarians and nonagenarians with Pseudomonas aeruginosa bacteremia: a multicenter retrospective study.
Infection
; 51(4): 1003-1012, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-36571672
13.
Diagnostic accuracy of Panbio™ rapid antigen test for SARS-CoV-2 in paediatric population.
BMC Pediatr
; 23(1): 433, 2023 08 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-37644389
14.
A paper biosensor for overcoming matrix effects interfering with the detection of sputum pyocyanin with competitive immunoassays.
Mikrochim Acta
; 190(11): 441, 2023 10 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-37845505
15.
Anthropometric characteristics of young elite sailors based on performance level.
J Exerc Sci Fit
; 21(1): 125-130, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36583096
16.
Simulated Intravenous versus Inhaled Tobramycin with or without Intravenous Ceftazidime Evaluated against Hypermutable Pseudomonas aeruginosa via a Dynamic Biofilm Model and Mechanism-Based Modeling.
Antimicrob Agents Chemother
; 66(3): e0220321, 2022 03 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-35041509
17.
Selection of AmpC ß-Lactamase Variants and Metallo-ß-Lactamases Leading to Ceftolozane/Tazobactam and Ceftazidime/Avibactam Resistance during Treatment of MDR/XDR Pseudomonas aeruginosa Infections.
Antimicrob Agents Chemother
; 66(2): e0206721, 2022 02 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34930034
18.
Rapid Identification and Classification of Pathogens That Produce Carbapenemases and Cephalosporinases with a Colorimetric Paper-Based Multisensor.
Anal Chem
; 94(26): 9442-9449, 2022 07 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35748103
19.
Improved cytometric analysis of untouched lung leukocytes by enzymatic liquefaction of sputum samples.
Biol Proced Online
; 24(1): 17, 2022 Nov 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-36396988
20.
In vivo translational assessment of the GES genotype on the killing profile of ceftazidime, ceftazidime/avibactam and meropenem against Pseudomonas aeruginosa.
J Antimicrob Chemother
; 77(10): 2803-2808, 2022 09 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-35848936